ESC Premium Access

Combination therapy with renin-angiotensin system inhibitors and statins is associated with reduced incidence of new-onset atrial fibrillation in hypertensive patients

Topic: Target Organ Damage/Left Ventricular Hypertrophy

Congress Presentation

About the speaker

Doctor Takeshi Horio

Ishikiriseiki Hospital, Higashi-Osaka (Japan)
0 follower

3 more presentations in this session

Fatal attraction: hypertension and atrial fibrillation - Current knowledge

Speaker: Professor A. Manolis (Athens, GR)


Long-term systolic blood pressure trajectories predict risk of incident atrial fibrillation in a general population cohort study

Speaker: Doctor E. Sharashova (Tromso, NO)


Efficacy and safety of edoxaban vs warfarin stratified by achieved blood pressure in 19,754 patients with hypertension in ENGAGE AF-TIMI 48

Speaker: Professor S. Park (Seoul, KR)


Access the full session

Hypertension and Atrial Fibrillation

Speakers: Doctor T. Horio, Professor A. Manolis, Doctor E. Sharashova, Professor S. Park

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb